Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MBX Biosciences Doses First Patient in Phase 2 Avail™ Trial of MBX 2109 for the Treatment of Hypoparathyroidism
-
Sofwave Receives FDA Clearance for Pure Impact™ in Strengthening and Firming of Arms in the U.S.
-
Westwood Hires Chris Doran as Head of ETF Distribution & National Accounts
-
StemSation International Provides Corporate Updates
-
UNITY Biotechnology to Participate in Upcoming Investor Conferences
-
Hivello and Zulu partner to advance decentralized infrastructure and Bitcoin ecosystem
-
Navigator Gas Announces Entry Into $147.6 Million Secured Term Loan and Revolving Credit Facility
-
LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia
-
Kandi Technologies and Hartford Industrial Sign Formal Partnership Agreement
-
LiveOne (Nasdaq: LVO) Presents 245th Edition: MusicLives Hamptons Festival Featuring KYLE and Jeremih
-
Stryker announces definitive agreement to acquire care.ai, a leading virtual care and ambient intelligence solutions platform
-
Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Superior Group of Companies Announces New Stock Repurchase Plan
-
Annexon Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
-
Mindera Health Announces Appointment of Kamal Adawi as Chief Financial Officer
-
Aeries Technology Selected by Diligent to Establish a Customer Success Center of Excellence in Guadalajara
-
Shoals Technologies Group Appoints Niharika Taskar Ramdev to Its Board of Directors
-
Westwood Hires Chris Doran as Head of ETF Distribution & National Accounts
-
Navigate360 Launches Free Self-Harm Intervention Tool for K-12 Schools Nationwide
-
New National Chuck E. Cheese Fun Pass Membership Program Offers Unlimited Visits for as Low as $7.99 a Month
-
New Research Reveals Major Disparities in Access to Living Wages in U.S. Workforce
-
Yoshitsu Co., Ltd Establishes Franchise Network for Southeast Asia Expansion
-
Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI
-
4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
-
Hopebridge Continues to Grow Autism Therapy Services by Opening a New Location in Ohio
-
Schouw & Co. share buy-back programme, week 32 2024
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Pyxis Tankers Announces Financial Results for the Three Months Ended June 30, 2024
-
Spryker Achieves Manufacturing as its Fifth AWS Competency
-
Accredited Solutions Finalizes Balance Sheet Restructuring, to Record $3.1 Million One-Time Income Event Following Successful Closing of Exchange Agreements with Debt Holders
-
Timberwolves Name Sezzle “Official Jersey Patch Partner”
-
ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems for Military Operational Use
-
International wine expo opens in China to boost industry exchange
-
Bitget Lists Ginnan The Cat (GINNAN) in the Innovation and Meme Zone
-
World-class wine-producing zone emerges in northwest China's Gobi Desert
-
World-class wine-producing zone emerges in northwest China's Gobi Desert
-
Eclipse Life Sciences Initiates Phase 2 Study for Novel Ophthalmology Steroid Implant for Diabetic Macular Edema (DME)
-
Trailbreaker Expands Watchtower Zone Gold Anomaly to 350m x 200m Along a 3km Gold Trend at Castle Rock Property
-
Sernova Corp. Announces Appointment of New Chief Executive Officer
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Allot to Release Second Quarter 2024 Earnings and Host Conference Call on August 27, 2024
-
ShepskyAI to Introduce Adaptive AI-Driven Bots for Crypto Trading in Upcoming Launch
-
Evome Medical Technologies Reports Second Quarter 2024 Financial Results
-
Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference
-
Dragonfly Energy Powers Highway Transport's Fleet with Battle Born All-Electric APUs
-
Dragonfly Energy Powers Highway Transport's Fleet with Battle Born All-Electric APUs
-
Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
-
Bitech Technologies Announces Business Update and Provides Key 2024 Milestones for BESS Projects
-
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO® (vorasidenib)
-
Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases
